Autopsy report · NCT00942838

Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity

“PI decision due to under accrual.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

University of Utah

Sponsor type

University, hospital or other

Conditions

Recurrent Ovarian Carcinoma

Interventions

Cisplatin; Whole Abdomen Radiotherapy

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Developing and Validating Fertilit-e
  “PI decision - competing study” (72% match in meaning)
• Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus
  “PI decision based on reduced staffing and funds.” (70% match in meaning)
• Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma
  “Study closed by PI due to lower than expected accrual.” (67% match in meaning)
• Second Study to Assess Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Long Standing Persistent Atrial Fibrillation
  “PI discretion” (65% match in meaning)
• Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
  “Per PI due to poor/inadequate accrual.” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.